<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03842150</url>
  </required_header>
  <id_info>
    <org_study_id>XH-19-001</org_study_id>
    <nct_id>NCT03842150</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study</brief_title>
  <official_title>Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Better survival and prognosis of biliary atresia (BA) depend on early diagnosis and timely
      Kasai portoenterostomy. Identifying BA from other causes of infantile cholestasis at early
      stage of the disease still remains a major challenge. In this study, the investigators aim to
      develop and validate a scoring system to screen BA in infants with cholestasis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development and Validation a Screening Score for the biliary atresia in infantile cholestasis</measure>
    <time_frame>1 weeks</time_frame>
    <description>Developed a scoring system according to clinical, laboratory, imaging features of BA and test it in the clinical work. The score system might including clay stool, γ-glutamyl transpeptadase, the results of ultrasound and subscales selected for logistic regression. The total score would sum all the subscales up.The investigators grade the patients with the cholestasis screen score to identify patients with biliary atresia. Patients with score ≤ 15 points considered to be the low-risk group, and patients with risk score &gt; 15 points considered the high-risk group, and the score model has no maximum or minimum value.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Biliary Atresia</condition>
  <condition>Neonatal Cholestasis</condition>
  <condition>Infantile Hepatitis Syndrome</condition>
  <arm_group>
    <arm_group_label>derivation cohort</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>validation cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>biliary atresia screen score</intervention_name>
    <description>The investigators aim to develop a scoring system according to clinical, laboratory, imaging features of biliary atresia in the derivation dataset and tested in the validation datasets.</description>
    <arm_group_label>derivation cohort</arm_group_label>
    <arm_group_label>validation cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        infants with cholestasis inclduing biliary atresia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical diagnosis of neonatal cholestasis Age at first visit less than 90 days after birth

        Exclusion Criteria:

        Severe congenital malformation Subjects with missing data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yongjun Zhang, doctor</last_name>
    <phone>+8602125078310</phone>
    <email>zhangyongjun@sjtu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongjun Zhang, doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>February 17, 2019</last_update_submitted>
  <last_update_submitted_qc>February 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The investigators plan to share all the individual participant data information available to our cooperative hospitals through emails</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

